Table 3 Distribution of ARV-related adverse events by ARV drug regimen among TB patients receiving ART at MPC, Malawi £
ARV-related adverse effects | Total (n = 284) | d4T/3TC/NVP (n = 110) | TDF/3TC/EFV (n = 174) | |||
|---|---|---|---|---|---|---|
Total with one or more ARV-related adverse events* | 82 | 29% | 39 | 35% | 43 | 25% |
Anorexia | 6 | 2% | 2 | 2% | 4 | 2% |
Leg pain/numbness | 40 | 14% | 24 | 22% | 16 | 9% |
Jaundice | 1 | 0% | 0 | 0% | 1 | 1% |
Skin rash | 9 | 3% | 5 | 5% | 4 | 2% |
Vomit | 22 | 8% | 4 | 4% | 18 | 10% |
Hepatitis | 1 | 0% | 0 | 0% | 1 | 1% |
Abdominal pain | 5 | 2% | 2 | 2% | 3 | 2% |
Fever | 5 | 2% | 2 | 2% | 3 | 2% |
Other | 9 | 3% | 5 | 5% | 4 | 2% |